Public offering yields $115M for BioCryst
June 03, 2014 at 16:31 PM EDT
Thanks to a successful public offering, Durham-based BioCryst Pharmaceuticals has some additional cash to fund accelerated testing for one of its drugs...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.